Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* |
|
Axsome Therapeutics, Inc.
|
|
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
|
|
05464T104
(CUSIP Number)
|
|
December 31, 2021
(Date of Event which Requires Filing of this Statement)
|
|
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
||
|
|
||
|
[
|
X
|
] Rule 13d-1(b)
|
|
[
|
] Rule 13d-1(c)
|
|
|
[
|
] Rule 13d-1(d)
|
|
|
|
||
|
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
|
||
|
|
||
|
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
||
|
|
||
|
SCHEDULE 13G
|
||||||
|
CUSIP No. 05464T104
|
||||||
|
|
1.
|
Names of Reporting Persons.
Iridian Asset Management LLC
I.R.S. Identification Nos. of above persons (entities only).
|
||||
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [X ] (b) [ ] |
||||
|
|
3.
|
SEC USE ONLY
|
||||
|
|
4.
|
Citizenship or Place of Organization
Delaware
|
||||
|
Number of
Shares Beneficially Owned by Each Reporting Person With: |
5.
|
Sole Voting Power
N/A |
||||
|
6.
|
Shared Voting Power
N/A |
|||||
|
7.
|
Sole Dispositive Power
N/A |
|||||
|
8.
|
Shared Dispositive Power
N/A |
|||||
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
N/A |
||||
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ]
|
||||
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
N/A
|
||||
|
|
12.
|
Type of Reporting Person
IA
|
||||
|
2
|
||||||
|
SCHEDULE 13G
|
||||||
|
CUSIP No. 05464T104
|
||||||
|
|
1.
|
Names of Reporting Persons.
David L. Cohen
I.R.S. Identification Nos. of above persons (entities only).
|
||||
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ X ] (b) [ ] |
||||
|
|
3.
|
SEC USE ONLY
|
||||
|
|
4.
|
Citizenship or Place of Organization
United States
|
||||
|
Number of
Shares Beneficially Owned by Each Reporting Person With: |
5.
|
Sole Voting Power
N/A |
||||
|
6.
|
Shared Voting Power
N/A |
|||||
|
7.
|
Sole Dispositive Power
N/A |
|||||
|
8.
|
Shared Dispositive Power
N/A |
|||||
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
N/A |
||||
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ]
|
||||
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
N/A
|
||||
|
|
12.
|
Type of Reporting Person
IN
|
||||
|
3
|
||||||
|
SCHEDULE 13G
|
||||||
|
CUSIP No. 05464T104
|
||||||
|
|
1.
|
Names of Reporting Persons.
Harold J. Levy
I.R.S. Identification Nos. of above persons (entities only).
|
||||
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [X] (b) [ ] |
||||
|
|
3.
|
SEC USE ONLY
|
||||
|
|
4.
|
Citizenship or Place of Organization
United States
|
||||
|
Number of
Shares Beneficially Owned by Each Reporting Person With: |
5.
|
Sole Voting Power
0 |
||||
|
6.
|
Shared Voting Power
N/A |
|||||
|
7.
|
Sole Dispositive Power
N/A |
|||||
|
8.
|
Shared Dispositive Power
N/A |
|||||
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
N/A |
||||
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ]
|
||||
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
N/A
|
||||
|
|
12.
|
Type of Reporting Person
IN
|
||||
|
4
This Amendment amends in its entirety the Schedule 13G filed for the month ended December 31, 2020.
|
||||||
|
Item 1.
|
||||||
|
|
(a)
|
Name of Issuer
Axsome Therapeutics, Inc. |
||||
|
|
(b)
|
Address of Issuer's Principal Executive Offices
22 Cortlandt Street, New York, NY 10007
|
||||
|
Item 2.
|
||||||
|
|
(a)
|
Name of Person Filing
This Statement is being filed by and on behalf of Iridian Asset Management LLC ("Iridian"), David L. Cohen ("Cohen") and Harold J. Levy ("Levy") (collectively, the "Reporting Persons"). Iridian is majority owned by Arovid Associates LLC, a Delaware limited liability company owned and controlled by the following: 12.5% by Cohen, 12.5%
by Levy, 37.5% by LLMD LLC, a Delaware limited liability company, and 37.5% by ALHERO LLC, a Delaware limited liability company. LLMD LLC is owned 1% by Cohen, and 99% by a family trust controlled by Cohen. ALHERO LLC is owned 1% by Levy and
99% by a family trust controlled by Levy.
|
||||
|
|
(b)
|
Address of Principal Business Office or, if none, Residence
The principal business address of the Reporting Persons is 276 Post Road West, Westport, CT 06880-4704. |
||||
|
|
(c)
|
Citizenship or Place of Organization
Iridian is a Delaware limited liability company. Cohen and Levy are US citizens. |
||||
|
|
(d)
|
Title of Class of Securities
Common Stock, par value $0.0001 per share |
||||
|
|
(e)
|
CUSIP Number
05464T104 |
||||
|
Item 3.
|
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
|||||
|
|
(a)
|
[ ]
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
|||
|
|
(b)
|
[ ]
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|||
|
|
(c)
|
[ ]
|
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|||
|
|
(d)
|
[ ]
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
|
|||
|
|
(e)
|
[ ]
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
|||
|
|
(f)
|
[ ]
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|||
|
|
(g)
|
[ ]
|
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
|||
|
|
(h)
|
[ ]
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|||
|
|
(i)
|
[ ]
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C.
80a-3);
|
|||
|
|
(j)
|
[ x]
|
Group, in accordance with §240.13d-1(b)(1)(ii)(J).
|
|||
|
Item 4.
|
Ownership.
|
|||||
|
|
(a) and (b)
|
Amount beneficially owned and Percent of Class:
Not applicable.
|
||||
|
|
||||||
|
|
(c)
|
Power to vote or dispose.
Not applicable.
|
||||
|
Item 5.
|
Ownership of Five Percent or Less of a Class
|
|||||
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of
more than five percent of the class of securities, check the following [XX].
|
||||||
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person
|
|||||
|
Not Applicable
|
||||||
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
|
|||||
|
Not Applicable.
|
||||||
|
Item 8.
|
Identification and Classification of Members of the Group
|
|||||
|
Iridian is an investment adviser registered under Section 203 of the Investment Advisers Act of 1940, and its principal business is managing a number
of accounts containing securities over which Iridian has voting and dispositive power.
Each of Messrs. Cohen and Levy has a controlling interest in Iridian and serves as Co-Chief Executive Officer of Iridian.
|
||||||
|
Item 9.
|
Notice of Dissolution of Group
|
|||||
|
Not Applicable
|
||||||
|
Item 10.
|
Certification
|
|||
|
By signing below the undersigned certifies that, to the best of its or his knowledge and belief, the securities referred to above were
acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of and do not have the effect of changing or influencing the control of the issuer of the securities and were not acquired
and are not held in connection with or as a participant in any transaction having such purpose or effect.
|
||||
|
SIGNATURE
|
||||
|
After reasonable inquiry and to the best of its or his knowledge and belief, we certify that the information set forth in this statement is true,
complete and correct.
|
||||
|
|
||||
|
Date: January 18, 2022
|
||||
|
|
IRIDIAN ASSET MANAGEMENT LLC
|
|||
|
|
By:
|
/s/ Jeffrey M. Elliott
_________________________
Jeffrey M. Elliott
|
||
|
|
Title:
|
Executive Vice President
|
||
|
|
||||
|
|
David L. Cohen
|
|||
|
|
By:
|
/s/ Jeffrey M. Elliott
_________________________
Jeffrey M. Elliott
|
||
|
|
Title:
|
Agent
|
||
|
|
||||
|
|
Harold J. Levy
|
|||
|
|
By:
|
/s/ Jeffrey M. Elliott
__________________________
Jeffrey M. Elliott
|
||
|
|
Title:
|
Agent
|
||